Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
NCT ID: NCT01250925
Last Updated: 2017-01-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
94 participants
INTERVENTIONAL
2010-08-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure
NCT00804999
Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients
NCT00799422
Corneal and Conjunctival Sensitivity and Staining Study
NCT00455455
A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses
NCT03235089
Clinical Evaluation of Reusable Soft Contact Lenses
NCT06119191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OPTI-FREE® RepleniSH®
33 participants will be assigned to use this lens care regimen during the six-week assessment period
OPTI-FREE® RepleniSH®
Contact Lens care regimen
Clear Care®
33 participants will be assigned to use this lens care regimen during the six-week assessment period
Clear Care®
Contact lens care regimen
ReNu MultiPlus® MultiPurpose Solution
33 participants will be assigned to use this lens care regimen during the six-week assessment period
ReNu MultiPlus® MultiPurpose Solution
Contact lens care regimen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ReNu MultiPlus® MultiPurpose Solution
Contact lens care regimen
OPTI-FREE® RepleniSH®
Contact Lens care regimen
Clear Care®
Contact lens care regimen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects must not have ever worn contact lenses.
3. Subjects must have normal, healthy eyes.
Exclusion Criteria
2. subjects must not have any ocular or systemic disease.
3. Subjects must not have history of ocular surgery/trauma within the last 6 months.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Iowa
OTHER
Alcon Research
INDUSTRY
Massachusetts Eye and Ear Infirmary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedram Hamrah, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts Eye and Ear Infirmary
Christine Sindt, OD
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa
Iowa City, Iowa, United States
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-04-029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.